Esther Villar

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)

Aňa Lluch, Carlos H. Barrios, Laura Torrecillas et al. · Journal of Clinical Oncology · 2019 · 143 citations · Full text

Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer

Manuel Cobo, Raquel Delgado, Silvia Gil et al. · Clinical & Translational Oncology · 2006 · 21 citations

Urology, Surgical Oncology, Genitourinary Cancer +7

The HLA-B7 allele confers susceptibility to breast cancer in Spanish women

Rocío Lavado-Valenzuela, Manuel Benavides, Esther Villar et al. · Immunology Letters · 2005 · 20 citations

Breast Oncology, Cancer Risk, Medicine +8

Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer

Miguel Martín, CH Barrios, Laura Torrecillas et al. · Cancer Research · 2019 · 10 citations

Surgical Oncology, Breast Oncology, Adjuvant Capecitabine +18